You searched for "regulation"
Eyes on the road – visual standards for car drivers
The author examines the current visual standards required by drivers and asks whether more needs to be done to make roads safer. Are the public adequately protected by the current system of visual standards required by drivers? In a survey...
Diagnostic accuracy of different keratoconus detection indices of pentacam in paediatric eyes
This is a retrospective study of 432 non-keratoconic eyes compared with 48 eyes with keratoconus (KC) or forme fruste KC (FFKC) in a paediatric population in Cairo, Egypt between December 2013 and October 2018. The authors discuss the rationale of...
Mid-term evaluation of the new Glaukos iStent
This is a prospective non-randomised interventional study to assess the efficacy and safety of the Glaukos GTS-400 iStent combined with cataract surgery. The patients enrolled in the study had cataract and primary open angle glaucoma, pseudoexfoliation glaucoma or ocular hypertension....Developing community eye care: the GOS package in Scotland
In the second in the series about community eye care in the home nations, Janet Pooley explains how Scotland has developed its services within GOS. The United Kingdom has devolved healthcare; the powers were transferred from Westminster to Scotland and...Changing the post cataract surgery review pathway – is patient safety compromised?
Cataract surgery continues to be the most commonly performed elective surgical procedure in the UK, with an annual rate of approximately 4150/100,000 people over the age of 65 accounting for a significant proportion of the surgical workload of most ophthalmologists...“I can see fine. Why do I need my eyes tested?”
Are routine eye examinations really necessary? The author asks whether frequent appointments in low-risk patients with normal results are actually cost-effective. It’s recommended that most people should get their eyes tested every two years.” [1] This message is widely publicised...Renewed momentum in ocular gene and cell therapy, broadening application to chronic disease
Gene and cell therapies offer the prospect of ground-breaking new avenues for the treatment of diseases, reflected in a renewed explosion of interest and investment in retinal gene therapy. Rod McNeil reports recent clinical trial readouts across a diverse range...Ophthalmic entrepreneurship: Reflections from an ophthalmic surgeon
For many ophthalmic trainees and newly appointed consultants, the idea of medical entrepreneurship can feel distant and sometimes uncomfortable. We are trained in a profession centred on patient care, ethics and service. The word entrepreneur, by contrast, often brings to...Diabetes macular oedema in pregnancy self-resolving postpartum
*Equally contributing co-first authors. Diabetic macular oedema (DMO) is a common clinical presentation to ophthalmology clinics. Ample evidence exists for management of DMO in non-pregnant patients. However, there is a paucity of evidence on the optimal management of DMO in...Paediatric choroidal neovascular membrane secondary to optic disc drusen
Choroidal neovascular membrane (CNVM) is a rare cause of visual impairment in paediatric populations and predominantly affects individuals aged over 50. CNVM is defined as the pathologic growth of new abnormal blood vessels which extend from the choroid and break...
